IMPACT FACTOR
2023
1.5
|
MNiSW
20*
|
Indexed in:
ESCI
Web of Science
Clarivate Analytics
|
JCI
0.31
Journal Citation Indicator
|
CiteScore 2023
2.8
|
NEW Guidelines for Authors!
* The
current MNiSW score is temporary and results from the decision of the Minister
of Science and Higher Education to withdraw scores from all journals that
received an increase in score in 2023. The decision is the result of the need
to develop a new scoring system. However, all articles published in 2023 are
awarded 200 MNiSW points, and the actual score for 2024 will be determined at
the end of the year. * Obecna
punktacja MEiN ma charakter tymczasowy i wynika z decyzji Ministra Nauki i
Szkolnictwa Wyższego o wycofaniu punktacji wszystkim czasopismom, które w 2023
r. uzyskały podwyższenie punktacji. Decyzja ta wynika z konieczności
opracowania nowego systemu punktacji. Natomiast wszystkie artykuły opublikowane
w roku 2023 otrzymują 200 punktów MNiSW, a ostateczna punktacja za rok 2024
zostanie ustalona na koniec roku.
Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.
Indexed in PubMed and Web of Science Core Collection
3/2021
vol. 7
|
|
Review article
Overview of lenvatinib as a targeted therapy
for advanced hepatocellular carcinoma
Obaid Rehman,
Urooj Jaferi,
Inderbir Padda,
Nimrat Khehra,
Harshan Atwal,
Dina Mossabeh,
Ranvir Bhangu
Clin Exp HEPATOL 2021; 7, 3: 249-257
Online publish date: 2021-10-11
DOI
:
https://doi.org/10.5114/ceh.2021.109312
Original paper
Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term
Mahmoud Atamla,
Johad Khoury,
Ihab Dabbah,
Rimma Kramsky,
Afif Yaacob,
Ella Veitsman,
Tarek Saadi
Clin Exp HEPATOL 2021; 7, 3: 258-263
Online publish date: 2021-09-20
DOI
:
https://doi.org/10.5114/ceh.2021.109192
Original paper
Effect of abdominal fat distribution on severity
of acute pancreatitis
Engin Beydogan,
Semih Gulle,
Celal Gezer,
Banu Boyuk
Clin Exp HEPATOL 2021; 7, 3: 264-269
Online publish date: 2021-10-11
DOI
:
https://doi.org/10.5114/ceh.2021.109345
Original paper
Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification
Maurizio Cesari,
Anna Chiara Frigo,
Salvatore Piano,
Paolo Angeli
Clin Exp HEPATOL 2021; 7, 3: 270-277
Online publish date: 2021-08-23
DOI
:
https://doi.org/10.5114/ceh.2021.108708
Original paper
Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis
Omid Emami Aleagha,
Forouzan Moeinzadeh,
Seyedeh Farnaz Moeini Shokouh,
Erkan Doğan,
Masoud Sadeghi
Clin Exp HEPATOL 2021; 7, 3: 278-285
Online publish date: 2021-10-12
DOI
:
https://doi.org/10.5114/ceh.2021.109424
Original paper
Prevalence and predictors of post-liver
transplantation metabolic bone diseases
Maha Elsabaawy,
Sameh Afify,
Gasser El-Azab,
Asmaa Gomaa,
Nabil Omar,
Mohamed Hashim,
Dalia Elsabaawy,
Helmy Elshazly
Clin Exp HEPATOL 2021; 7, 3: 286-292
Online publish date: 2021-10-11
DOI
:
https://doi.org/10.5114/ceh.2021.109412
Original paper
Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients
Ahmed Kamal,
Ahmed Ramadan,
Dalia Sherief,
Asmaa Hassan,
Nahla Nosair,
Maaly Mabrouk,
Eman Habeeb,
Tamer Haydra
Clin Exp HEPATOL 2021; 7, 3: 293-296
Online publish date: 2021-09-21
DOI
:
https://doi.org/10.5114/ceh.2021.109336
Original paper
Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study
Mona Mohammed Abdelrahman,
Asmaa A. Abdel-baset,
Mustafa Adel Younis,
Mahmoud Gaber Mahmoud,
Noha Saber Shafik
Clin Exp HEPATOL 2021; 7, 3: 297-304
Online publish date: 2021-09-23
DOI
:
https://doi.org/10.5114/ceh.2021.109225
Original paper
Evaluation of different diagnostic modalities of
minimal hepatic encephalopathy in cirrhotic patients:
case-control study
Tary Salman,
Maha Elsabaawy,
Mahmoud Omar,
Mohamed Afify,
Hossam Elezawy,
Samar Ghanem,
Osama Abdelraouf,
Eman Rewisha,
Nashwa Shebl
Clin Exp HEPATOL 2021; 7, 3: 312-319
Online publish date: 2021-09-23
DOI
:
https://doi.org/10.5114/ceh.2021.109292
Original paper
Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients
Eman Rewisha,
Tary Salman,
Omkolsoum Alhaddad,
Gamal Abo Raia,
Mary Naguib,
Shymaa Rashad,
Ahmed Abdelfattah,
Khaled Metwally,
Eman Abdelsameea
Clin Exp HEPATOL 2021; 7, 3: 320-327
Online publish date: 2021-09-22
DOI
:
https://doi.org/10.5114/ceh.2021.109293
|
